A multidimensional education program at substance dependence treatment centers improves patient knowledge and hepatitis C care

被引:14
作者
Marinho, Rui Tato [1 ]
Costa, Antonio [2 ]
Pires, Teodomiro [3 ]
Raposo, Helena [4 ]
Vasconcelos, Carlos [5 ]
Polonia, Cristina [6 ]
Borges, Joaquim [7 ]
Soares, Mariana [8 ]
Vilar, Graca [9 ]
Nogueira, Ana Maria [10 ]
机构
[1] Univ Lisbon, Dept Gastroenterol & Hepatol, Fac Med, Hosp Santa Maria,Ctr Hosp Lisboa Norte, Av Prof Egas Moniz, P-1649035 Lisbon, Portugal
[2] UD Ctr Taipas, Parque Saude Lisboa Av Brasil 53,Pavilhao 2, P-1749002 Lisbon, Portugal
[3] ETET Almada, Rua Terras Cortes Reais 1, P-2805025 Almada, Portugal
[4] ETET Barreiro, Rua Almirante Reis 50, P-2830326 Barreiro, Portugal
[5] ETET Gondomar, Rua Caminho Pevidal,R-C S-N, P-4420264 Gondomar, Portugal
[6] ETET Setubal, Praca Republ, P-2900587 Setubal, Portugal
[7] ETET Figueira da Foz, Rua Doutor Calado 2, P-3080153 Figueira Da Foz, Portugal
[8] ETET Eixo Oeiras Cascais, Rua Prof Orlando Ribeiro 3A,B,5A,B & 7, P-2740222 Oporto, Salvo, Portugal
[9] SICAD Gen Directorate Intervent Addict Behav & De, Ave Republ 61,3 Piso, P-1050189 Lisbon, Portugal
[10] MSD Portugal, Edificio Vasco da Gama 19, P-2770192 Paco De Arcos, Portugal
关键词
Hepatitis C; Health education program; Treatment access; Substance abuse; People who inject drugs; Chronic hepatitis C treatment; INJECT DRUGS; VIRUS HCV; BARRIERS; USERS; PEOPLE; EPIDEMIOLOGY; PREVENTION; INFECTION; ADHERENCE; ATTITUDES;
D O I
10.1186/s12879-016-1883-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: HCV treatment among people who inject drugs (PWID) is low. Education programs may be suitable strategies to improve patients' knowledge about their condition and to overcome barriers to access treatment. Methods: The Health Educational Program (HEP) consisted of patient workshops and educational videos and leaflets, and healthcare professionals' workshops. HEP was implemented at seven substance dependence treatment centers (STDC) in Portugal. The study comprised two cross-sectional evaluations conducted before and after HEP. At both evaluations, adult patients with confirmed HCV diagnosis and registered in the STDC were consecutively included. For patients that completed both evaluations, the overall knowledge score were calculated and compared with McNemar test. Linear regression modelling was used to evaluate factors associated with baseline knowledge. Rates of referral and attendance to referral specialist, treatment proposal, initiation and retention at both evaluations were also compared with McNemar test. Results: Overall, 504 patients with chronic hepatitis C were included: 78 % male, mean age 42.3 +/- 6.6 years, 14 % school education <= 4 years, disease duration 11.0 +/- 6.0 years and 26 % HIV co-infected. A higher baseline knowledge was independently associated with educational level = 10 years (regression coefficient [B] = 15.13, p < 0.001), current use of intravenous drugs (B = 7.99, p = 0.038), previous referral for treatment (B = 4.26, p = 0.008) and previous HCV treatment (B = 5.40, p = 0.003). Following HEP, mean knowledge score increased from 69 % to 79 % (p < 0.001). The rate of patient referral to a liver specialist increased from 56.2 % to 67.5 % (p < 0.001). Conclusions: An HEP conducted at STDCs improved significantly patient knowledge about hepatitis C, even among patients with a high baseline knowledge. The HEP has also increased the rate of referral to the liver specialist and showed a great potential to support healthcare professionals in managing HCV. Education programs may promote treatment access among PWID, a population that represents the majority of HCV infected patients.
引用
收藏
页数:11
相关论文
共 47 条
  • [1] Anjo J., 2014, Jornal Portugues de gastrenterologia, V21, P44, DOI [DOI 10.1016/J.JPG.2014.03.001, 10.1016/j.jpg.2014.03.001]
  • [2] Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: A comprehensive approach
    Birkhead, Guthrie S.
    Klein, Susan J.
    Candelas, Alma R.
    O'Connell, Daniel A.
    Rothman, Jeffrey R.
    Feldman, Ira S.
    Tsui, Dennis S.
    Cotroneo, Richard A.
    Flanigan, Colleen A.
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2007, 18 (05) : 417 - 425
  • [3] Tangible Resources for Preparing Patients for Antiviral Therapy for Chronic Hepatitis C
    Bonner, Jason E.
    Barritt, A. Sidney
    Fried, Michael W.
    Evon, Donna M.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (06) : 1439 - 1444
  • [4] Historical epidemiology of hepatitis C virus (HCV) in selected countries
    Bruggmann, P.
    Berg, T.
    Ovrehus, A. L. H.
    Moreno, C.
    Brandao Mello, C. E.
    Roudot-Thoraval, F.
    Marinho, R. T.
    Sherman, M.
    Ryder, S. D.
    Sperl, J.
    Akarca, U.
    Balik, I.
    Bihl, F.
    Bilodeau, M.
    Blasco, A. J.
    Buti, M.
    Calinas, F.
    Calleja, J. L.
    Cheinquer, H.
    Christensen, P. B.
    Clausen, M.
    Coelho, H. S. M.
    Cornberg, M.
    Cramp, M. E.
    Dore, G. J.
    Doss, W.
    Duberg, A. S.
    El-Sayed, M. H.
    Ergor, G.
    Esmat, G.
    Estes, C.
    Falconer, K.
    Felix, J.
    Ferraz, M. L. G.
    Ferreira, P. R.
    Frankova, S.
    Garcia-Samaniego, J.
    Gerstoft, J.
    Giria, J. A.
    Goncales, F. L., Jr.
    Gower, E.
    Gschwantler, M.
    Guimaraes Pessoa, M.
    Hezode, C.
    Hofer, H.
    Husa, P.
    Idilman, R.
    Kaberg, M.
    Kaita, K. D. E.
    Kautz, A.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 5 - 33
  • [5] A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
    Cornberg, Markus
    Razavi, Homie A.
    Alberti, Alfredo
    Bernasconi, Enos
    Buti, Maria
    Cooper, Curtis
    Dalgard, Olav
    Dillion, John F.
    Flisiak, Robert
    Forns, Xavier
    Frankova, Sona
    Goldis, Adrian
    Goulis, Ioannis
    Halota, Waldemar
    Hunyady, Bela
    Lagging, Martin
    Largen, Angela
    Makara, Michael
    Manolakopoulos, Spilios
    Marcellin, Patrick
    Marinho, Rui T.
    Pol, Stanislas
    Poynard, Thierry
    Puoti, Massimo
    Sagalova, Olga
    Sibbel, Scott
    Simon, Krzysztof
    Wallace, Carolyn
    Young, Kendra
    Yurdaydin, Cihan
    Zuckerman, Eli
    Negro, Francesco
    Zeuzem, Stefan
    [J]. LIVER INTERNATIONAL, 2011, 31 : 30 - 60
  • [6] Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008
    Denniston, Maxine M.
    Klevens, R. Monina
    McQuillan, Geraldine M.
    Jiles, Ruth B.
    [J]. HEPATOLOGY, 2012, 55 (06) : 1652 - 1661
  • [7] The changing therapeutic landscape for hepatitis C
    Dore, Gregory J.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2012, 196 (10) : 629 - 632
  • [8] European Monitoring Centre for Drugs and Drug Addiction, 2015, DRUG TREATM OV PORT
  • [9] Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection
    Fishbein, DA
    Lo, YT
    Reinus, JF
    Gourevitch, MN
    Klein, RS
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (03) : 1367 - 1375
  • [10] General-Directorate for Intervention on Addictive Behaviours and Dependencies, 2013, STAT SYN